PT3333165T - Derivado de piperazina - Google Patents
Derivado de piperazinaInfo
- Publication number
- PT3333165T PT3333165T PT168330124T PT16833012T PT3333165T PT 3333165 T PT3333165 T PT 3333165T PT 168330124 T PT168330124 T PT 168330124T PT 16833012 T PT16833012 T PT 16833012T PT 3333165 T PT3333165 T PT 3333165T
- Authority
- PT
- Portugal
- Prior art keywords
- piperazine derivative
- piperazine
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015154601 | 2015-08-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3333165T true PT3333165T (pt) | 2019-10-29 |
Family
ID=57943013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT168330124T PT3333165T (pt) | 2015-08-04 | 2016-08-02 | Derivado de piperazina |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US10301286B2 (pt) |
| EP (1) | EP3333165B1 (pt) |
| JP (1) | JP6693520B2 (pt) |
| KR (1) | KR20180032585A (pt) |
| CN (1) | CN107849018B (pt) |
| AR (1) | AR105582A1 (pt) |
| AU (1) | AU2016302648A1 (pt) |
| CA (1) | CA2995188A1 (pt) |
| CO (1) | CO2018002416A2 (pt) |
| ES (1) | ES2753227T3 (pt) |
| HK (1) | HK1251548A1 (pt) |
| IL (1) | IL257264A (pt) |
| MX (1) | MX2018001503A (pt) |
| PH (1) | PH12018500239A1 (pt) |
| PL (1) | PL3333165T3 (pt) |
| PT (1) | PT3333165T (pt) |
| RU (1) | RU2731913C2 (pt) |
| SG (1) | SG11201800882YA (pt) |
| TW (1) | TW201718548A (pt) |
| WO (1) | WO2017022733A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6908041B2 (ja) * | 2016-07-19 | 2021-07-21 | アステラス製薬株式会社 | ピペラジン誘導体 |
| CN112824530A (zh) * | 2019-11-20 | 2021-05-21 | 中国科学院深圳先进技术研究院 | 一种hek293f悬浮细胞高效电转染方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6911447B2 (en) * | 2001-04-25 | 2005-06-28 | The Procter & Gamble Company | Melanocortin receptor ligands |
| US7456184B2 (en) * | 2003-05-01 | 2008-11-25 | Palatin Technologies Inc. | Melanocortin receptor-specific compounds |
| JP2005527492A (ja) * | 2002-01-23 | 2005-09-15 | イーライ・リリー・アンド・カンパニー | メラノコルチン受容体アゴニスト |
| TW200504033A (en) * | 2002-10-23 | 2005-02-01 | Procter & Gamble | Melanocortin receptor ligands |
| US7160886B2 (en) * | 2003-03-03 | 2007-01-09 | Merck & Co., Inc. | Acylated piperazine derivatives as melanocortin-4 receptor agonists |
| CN1816337A (zh) * | 2003-05-01 | 2006-08-09 | 帕拉坦技术公司 | 黑素皮质素受体特异性化合物 |
| WO2005102340A1 (en) * | 2003-05-30 | 2005-11-03 | Palatin Technologies, Inc. | Piperazine melanocortin-specific compounds |
| US20050192286A1 (en) * | 2003-10-22 | 2005-09-01 | Neurocrine Biosciences, Inc. | Ligands of melanocortin receptors and compositions and methods related thereto |
| GB0402492D0 (en) | 2004-02-04 | 2004-03-10 | Pfizer Ltd | Pharmaceutically active compounds |
| CA2574156A1 (en) * | 2004-07-19 | 2006-02-23 | Merck & Co., Inc. | Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| JP2009503048A (ja) * | 2005-08-01 | 2009-01-29 | ファイザー・リミテッド | 尿路機能障害を治療するためのｍｃ４ｒ作動薬 |
| WO2007041061A2 (en) * | 2005-09-30 | 2007-04-12 | Merck & Co., Inc. | Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| CN101426782B (zh) * | 2006-02-23 | 2012-10-31 | 辉瑞股份有限公司 | 黑皮质素4型受体激动剂哌啶羰基吡咯烷 |
| SG185849A1 (en) | 2006-02-23 | 2012-12-28 | Pfizer Ltd | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines |
| WO2008039418A2 (en) | 2006-09-27 | 2008-04-03 | Merck & Co., Inc. | Acylated piperidine derivatives as melanocortin-4 receptor modulators |
| WO2010015972A1 (en) * | 2008-08-06 | 2010-02-11 | Pfizer Limited | Diazepine and diazocane compounds as mc4 agonists |
| CN112194649A (zh) | 2014-05-29 | 2021-01-08 | 田边三菱制药株式会社 | 吡咯烷化合物及作为黑皮质素受体激动剂的用途 |
-
2016
- 2016-08-02 EP EP16833012.4A patent/EP3333165B1/en active Active
- 2016-08-02 WO PCT/JP2016/072569 patent/WO2017022733A1/ja active Application Filing
- 2016-08-02 RU RU2018107711A patent/RU2731913C2/ru active
- 2016-08-02 MX MX2018001503A patent/MX2018001503A/es active IP Right Grant
- 2016-08-02 AU AU2016302648A patent/AU2016302648A1/en not_active Abandoned
- 2016-08-02 KR KR1020187003183A patent/KR20180032585A/ko not_active Application Discontinuation
- 2016-08-02 ES ES16833012T patent/ES2753227T3/es active Active
- 2016-08-02 US US15/749,375 patent/US10301286B2/en active Active
- 2016-08-02 PT PT168330124T patent/PT3333165T/pt unknown
- 2016-08-02 CN CN201680045994.6A patent/CN107849018B/zh active Active
- 2016-08-02 JP JP2017533072A patent/JP6693520B2/ja not_active Expired - Fee Related
- 2016-08-02 PL PL16833012T patent/PL3333165T3/pl unknown
- 2016-08-02 CA CA2995188A patent/CA2995188A1/en not_active Abandoned
- 2016-08-02 SG SG11201800882YA patent/SG11201800882YA/en unknown
- 2016-08-03 TW TW105124624A patent/TW201718548A/zh unknown
- 2016-08-03 AR ARP160102367A patent/AR105582A1/es unknown
-
2018
- 2018-01-30 PH PH12018500239A patent/PH12018500239A1/en unknown
- 2018-01-31 IL IL257264A patent/IL257264A/en unknown
- 2018-03-02 CO CONC2018/0002416A patent/CO2018002416A2/es unknown
- 2018-08-22 HK HK18110806.3A patent/HK1251548A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2731913C2 (ru) | 2020-09-09 |
| PL3333165T3 (pl) | 2019-12-31 |
| AU2016302648A1 (en) | 2018-02-22 |
| CO2018002416A2 (es) | 2018-06-12 |
| IL257264A (en) | 2018-03-29 |
| WO2017022733A1 (ja) | 2017-02-09 |
| CA2995188A1 (en) | 2017-02-09 |
| JPWO2017022733A1 (ja) | 2018-05-31 |
| EP3333165B1 (en) | 2019-09-18 |
| RU2018107711A3 (pt) | 2019-11-21 |
| CN107849018B (zh) | 2021-02-23 |
| JP6693520B2 (ja) | 2020-05-13 |
| EP3333165A1 (en) | 2018-06-13 |
| US10301286B2 (en) | 2019-05-28 |
| MX2018001503A (es) | 2018-04-24 |
| HK1251548A1 (zh) | 2019-02-01 |
| US20180230131A1 (en) | 2018-08-16 |
| RU2018107711A (ru) | 2019-09-05 |
| CN107849018A (zh) | 2018-03-27 |
| PH12018500239A1 (en) | 2018-08-13 |
| AR105582A1 (es) | 2017-10-18 |
| TW201718548A (zh) | 2017-06-01 |
| KR20180032585A (ko) | 2018-03-30 |
| ES2753227T3 (es) | 2020-04-07 |
| SG11201800882YA (en) | 2018-03-28 |
| EP3333165A4 (en) | 2019-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1255045A1 (zh) | 取代的氧代吡啶衍生物 | |
| IL253381A0 (en) | History of h9-pyrrolo-dipyridine | |
| ZA201704602B (en) | Dihydroindolizinone derivative | |
| HK1245258A1 (zh) | 新的二氟酮酰胺衍生物 | |
| HUE050450T2 (hu) | Fluoralkil-fluorén-származékok | |
| IL248773A0 (en) | History of naphthyridinedione | |
| IL251005B (en) | Pyrido-oxazinone derivatives | |
| IL248772A0 (en) | A consequence of cyclohexyl pyridine | |
| IL248629A0 (en) | Substances containing diheteroaryl conjugated to cycloalkyl and their uses | |
| HK1251548A1 (zh) | 哌嗪衍生物 | |
| PT3489231T (pt) | Derivado de piperazina | |
| SG11201609359WA (en) | Pyrazine derivative | |
| HK1259107A1 (zh) | 氨基唑衍生物 |